Real-world effectiveness and safety of simnotrelvir/ritonavir for COVID-19: A nationwide, multicenter, prospective, observational cohort study in China.
Han B, Du C, Deng M, Tang R, Dong J, Song X, Qiao Y, Ni Z, Yang W, Yang J, Xiang T, Huang Y, Zhong Y, Zhang Z, Yang L, Yang J, Wang J, Zheng L, Ma L, Shou Z, Cao R, Ma J, He G, Yuan J, Pang C, Xu J, Huang J, Yuan X, Wu Y, Xiong Y, Zhang X, Liu H, Gao B, Chen H, Ma T, Dang S, Zhang Q, Yuan R, Wei Y, Xu T, Deng Z, Gong Y, Gao J, Jiang R.
Han B, et al. Among authors: zhang q, zhang z, zhang x.
J Infect. 2024 Dec;89(6):106339. doi: 10.1016/j.jinf.2024.106339. Epub 2024 Nov 7.
J Infect. 2024.
PMID: 39521253
Free article.